Cano Health, Inc. CANOQ

0.24 0.00 0.00% as of 28 Jun
Market cap
$6.6M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
P/E ratio
0.00 0.00 0.00 0.00 0.00 —
P/S ratio
0.00 0.09 0.94 0.00 0.00 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 —
P/Operating CF
(0.32) (3.95) (64.54) 9,795.16 0.00 —
P/B ratio
0.00 0.50 1.90 2,330.71 0.00 —
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 —
EV/Sales
(0.01) 0.47 1.42 0.00 0.00 —
EV/EBITDA
0.07 0.00 0.00 7,027.74 0.00 —
EV/Operating CF
0.19 (8.75) (19.41) (12,574.59) 0.00 —
EV/FCF
0.16 (6.54) (15.03) (5,450.15) 0.00 —
Quick Ratio
0.12 1.25 1.84 1.51 0.00 —
Current Ratio
0.13 1.63 1.97 1.65 0.00 —
Net Debt/EBITDA
0.10 (53.56) (9.54) 18.62 0.00 —
Debt/Assets
5.45% 55.10% 43.61% 81.22% 0.00% 0.00%
Debt/Equity
(0.10) 2.15 1.17 10.05 0.00 —
Asset Turnover
2.13 1.35 1.17 2.71 15,850.18 —
Operating CF/Net income
0.22 0.71 6.55 0.13 0.78 —
Capex/Depreciation
(0.03) (0.12) (0.63) (0.48) (1.26) —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 —
ROE
2,919.11% (32.06%) (4.25%) (286.43%) (79.12%) —
ROA
(40.40%) (10.18%) (1.31%) (23.14%) (86,754.39%) —
ROIC
0.00% (17.84%) (5.38%) (0.03%) 0.00% —
Return on Tangible Assets
50.46% (78.62%) (7.46%) (86.70%) 38,860.51% —
Average Days of Receivables
8.82 31.16 30.26 29.56 0.00 —
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
11.56% 15.42% 15.67% 12.50% 16.37% —
Intangible Assets out of Total Assets
0.68 0.66 0.74 0.75 0.00 0.00
Share Based Compensation of Revenue
0.26% 2.00% 1.74% 0.06% 0.05% —
Graham Net Nets
(94.83) (4.46) (0.68) 0.00 0.00 —
Graham Number
1,059.04 0.00 0.00 0.00 0.00 —
Earnings Yield
(4,906.41%) (77.68%) (2.27%) (0.03%) 0.00% —
Free Cash Flow Yield
(1,029.45%) (79.79%) (10.03%) (0.02%) 0.00% —
Revenue per Share
1,139.30 1,249.68 943.86 0.00 0.00 —
Operating CF per Share
(46.86) (66.77) (69.22) 0.00 0.00 —
Capex per Share
(6.98) (22.60) (20.15) 0.00 0.00 —
Free Cash Flow per Share
(53.84) (89.37) (89.37) 0.00 0.00 —
Cash per Share
34.10 12.47 95.70 0.00 0.00 —
Shareholders Equity per Share
(194.26) 225.52 468.34 0.00 0.00 —
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 —
Book value per Share
(194.26) 225.52 468.34 0.00 0.00 —
Free Cash Flow
(148.28) (195.87) (152.39) (21.31) (24.77) —
Working Capital
(1,232.60) 132.31 156.20 43.84 (0.05) —
Capital Expenditures
(19.23) (49.53) (34.35) (12.07) (9.31) —
Net Current Asset Value
(1,365.92) (1,093.90) (1,027.74) (453.55) (0.05) —
EV/EBIT
0.02 0.00 0.00 0.00 0.00 —
Capex to Sales
0.01 0.02 0.02 0.01 0.03 —
Net Profit Margin
(18.94%) (7.57%) (1.12%) (8.55%) (5.47%) —
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 —
Other line items
Depreciation/Fixed assets
11.61 3.18 0.64 0.66 0.00 —
Cash ROIC
47.61% (17.52%) (10.72%) (8.13%) 291,792.45% —
Accounts Receivable Turnover
20.27 14.92 16.03 8.32 0.00 —
Accounts Payable Turnover
0.00 0.00 0.00 0.00 — —
Inventory Turnover
— 0.00 0.00 0.00 — —
Average Days of Payables
0.00 0.00 0.00 0.00 — —
Days of Inventory on Hand
— 0.00 0.00 0.00 — —
Average Receivables
154.81 183.62 100.39 100.00 — —
Average Payables
107.04 93.28 56.10 52.00 — —
Average Inventory
— — 0.96 1.00 — —
Average Assets
1,471.33 2,036.23 1,378.86 307.12 0.02 —
Average Common Equity
(20.36) 646.42 424.10 24.81 25.00 —

Fold the line items

Columns are period end dates